54 related articles for article (PubMed ID: 7051039)
1. Disappearance of a urinary antigonadotrophin following HCG administration in Prader Willi syndrome.
Harris JC; Knigge KM
Prog Clin Biol Res; 1982; 92():273-82. PubMed ID: 7051039
[No Abstract] [Full Text] [Related]
2. Clinical effects of treatment for hypogonadism in male adolescents with Prader-Labhart-Willi syndrome.
Eiholzer U; Grieser J; Schlumpf M; l'Allemand D
Horm Res; 2007; 68(4):178-84. PubMed ID: 17374959
[TBL] [Abstract][Full Text] [Related]
3. Induction of menarche by clomiphene citrate in a fifteen-year-old girl with the Prader-Labhart-Willi syndrome.
Linde R; McNeil L; Rabin D
Fertil Steril; 1982 Jan; 37(1):118-20. PubMed ID: 7037461
[No Abstract] [Full Text] [Related]
4. Normal minipuberty of infancy in boys with Prader-Willi syndrome.
Fillion M; Deal CL; Van Vliet G
J Pediatr; 2006 Dec; 149(6):874-6. PubMed ID: 17137911
[TBL] [Abstract][Full Text] [Related]
5. Onset of menses in two adult patients with Prader-Willi syndrome treated with fluoxetine.
Warnock JK; Clayton AH; Shaw HA; O'Donnell T
Psychopharmacol Bull; 1995; 31(2):239-42. PubMed ID: 7491374
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone and respiratory compromise in Prader-Willi Syndrome.
Wilson SS; Cotterill AM; Harris MA
Arch Dis Child; 2006 Apr; 91(4):349-50. PubMed ID: 16551791
[TBL] [Abstract][Full Text] [Related]
7. Cardiac tamponade due to systemic lupus erythematosus in patient with Prader-Willi syndrome after growth hormone therapy.
Kuramochi Y; Kato T; Sudou M; Sugano H; Takagi H; Morita T
Lupus; 2007; 16(6):447-9. PubMed ID: 17664237
[TBL] [Abstract][Full Text] [Related]
8. Sudden death in Prader-Willi syndrome: brief review of five additional cases. Concerning the article by U. Eiholzer et al.: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS (Horm Res 2005;63:33-39).
Bakker B; Maneatis T; Lippe B
Horm Res; 2007; 67(4):203-4. PubMed ID: 17164585
[No Abstract] [Full Text] [Related]
9. The Prader-Willi phenotype of fragile X syndrome.
Nowicki ST; Tassone F; Ono MY; Ferranti J; Croquette MF; Goodlin-Jones B; Hagerman RJ
J Dev Behav Pediatr; 2007 Apr; 28(2):133-8. PubMed ID: 17435464
[TBL] [Abstract][Full Text] [Related]
10. Somatropin in Prader-Willi syndrome.
Prescrire Int; 2004 Feb; 13(69):21. PubMed ID: 15055219
[No Abstract] [Full Text] [Related]
11. Sudden death in growth hormone-treated children with Prader-Willi syndrome.
Van Vliet G; Deal CL; Crock PA; Robitaille Y; Oligny LL
J Pediatr; 2004 Jan; 144(1):129-31. PubMed ID: 14722532
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone therapy in children with Prader-Willi syndrome.
Franzese A; Romano A; Spagnuolo MI; Ruju F; Valerio G
J Pediatr; 2006 Jun; 148(6):846; author reply 846-7. PubMed ID: 16769405
[No Abstract] [Full Text] [Related]
13. Could bone tissue be a target for luteinizing hormone/chorionic gonadotropin?
Mansell JP; Bailey AJ; Yarram SJ
Mol Cell Endocrinol; 2007 Apr; 269(1-2):99-106. PubMed ID: 17368927
[TBL] [Abstract][Full Text] [Related]
14. [The probable anorexigenic effect of naloxone in the Prader-Labhart-Willi syndrome].
Mascherpa G; Cogliati F; Mauri R; Resentini M
Minerva Pediatr; 1982 Aug 15-31; 34(15-16):675. PubMed ID: 7121431
[No Abstract] [Full Text] [Related]
15. KIGS highlights: growth hormone treatment in Prader-Willi Syndrome.
Tauber M; Cutfield W
Horm Res; 2007; 68 Suppl 5():48-50. PubMed ID: 18174707
[No Abstract] [Full Text] [Related]
16. [Prader-Willi syndrome. Treatment with growth hormone in 2 cases].
Youlton R
Rev Med Chil; 2001 Oct; 129(10):1186-90. PubMed ID: 11775347
[TBL] [Abstract][Full Text] [Related]
17. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
[TBL] [Abstract][Full Text] [Related]
18. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.
Kolibianakis EM; Papanikolaou EG; Tournaye H; Camus M; Van Steirteghem AC; Devroey P
Fertil Steril; 2007 Nov; 88(5):1382-8. PubMed ID: 17445806
[TBL] [Abstract][Full Text] [Related]
19. [Bronchospasm during anesthesia in a patient with Prader-Willi syndrome].
Kawahito S; Kitahata H; Kimura H; Kohyama A
Masui; 1995 Dec; 44(12):1675-9. PubMed ID: 8583665
[TBL] [Abstract][Full Text] [Related]
20. Prader-Willi syndrome: medical prevention and behavioral challenges.
Benarroch F; Hirsch HJ; Genstil L; Landau YE; Gross-Tsur V
Child Adolesc Psychiatr Clin N Am; 2007 Jul; 16(3):695-708. PubMed ID: 17562587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
